Skip to main content
SpringerLink
Log in

Anthrax

  • Chapter
Physician’s Guide to Terrorist Attack

  • 142 Accesses

Abstract

The September 11, 2001 terrorist attacks, followed shortly thereafter by the dissemination of anthrax through the U.S. mail, has drawn considerable attention in both the medical and lay communities to the risks of bioterrorism. The word anthrax has caused hysteria in the minds of many Americans in recent months, as evidenced by the many hoaxes and false alarms dealt with by fire departments and other authorities. Anthrax remains a leading bioterrorism threat to military troops engaged in combat, as well as to civilian populations targeted by terrorists.

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as representing the opinion of the Department of the Army, the Department of the Air Force, or the Department of Defense.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Friedlander AM. Anthrax. In: Sidell FR, Takafuji ET, Franz DR, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Borden Institute, Washington, DC, 1997, pp. 467–478.

    Google Scholar 

  2. WuDunn S, Miller J, Broad W. How Japan germ terror alerted the world. New York Times May 26, 1998;A1,6.

    Google Scholar 

  3. Carus SW. Bioterrorism and Biocrimes: The Illicit Use of Biological Agents in the 20th Century. Center for Counterproliferation Research, National Defense University, Washington, DC, 1998.

    Google Scholar 

  4. Manchee RJ, Stewart WD. The decontamination of Gruinard Island. Chem Br 1988 July:690–691.

    Google Scholar 

  5. Monterey Institute for International Studies (chemical and biological weapons resource page). Chemical and Biological Weapons. Monterey Institute for International Studies, Monterey, CA, 2001.

    Google Scholar 

  6. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202–1208

    Article  PubMed  CAS  Google Scholar 

  7. Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002 updated recommendations for management. JAMA 2002;288:2236–2252.

    Article  Google Scholar 

  8. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax Connecticut, 2001. MMWR 2001;50:1077–1079.

    Google Scholar 

  9. Bartlett JG, Inglesby TV, Borio L. Management of anthrax. Clin Infect Dis 2002;35:851–859.

    Article  PubMed  Google Scholar 

  10. Office of Technology Assessment, US Congress. Proliferation of Weapons of Mass Destruction. US Government Printing Office, Washington, DC, 1993, pp. 53–55. Publication OTA-ISC-559.

    Google Scholar 

  11. Keppie J, Harris-Smith PW, Smith H. The chemical basis of the virulence of Bacillus anthracis, IX: Its aggressins and their mode of action. Br J Exp Pathol 1963;44:446–453.

    PubMed  CAS  Google Scholar 

  12. Inglesby, et al. Anthrax as a biological weapon. Medical and public health management. JAMA 1999;281:1735–1745.

    Article  PubMed  CAS  Google Scholar 

  13. Brachman P, Friedlander A. Anthrax. In: Plotkin S, Orenstein W, eds. Vaccines, 3rd ed. WB Saunders, Philadelphia, 1999, pp. 629–637.

    Google Scholar 

  14. Titball RW, Turnbull PC, Hutson RA. The monitoring and detection of Bacillus anthracis in the environment. J Appl Bacteriol. 1991;70(suppl):9S-18S.

    Article  Google Scholar 

  15. Friedlander AM, Welkos SL, Pitt MLM, et al. Postexposure prophylaxis against inhalational anthrax. J Infect Dis 1993;167:1239–1242.

    Article  PubMed  CAS  Google Scholar 

  16. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999;341:815–826.

    Article  PubMed  CAS  Google Scholar 

  17. Henderson DW, Peacock S, Belton FC. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg 1956;54:28–36.

    Article  CAS  Google Scholar 

  18. Brachman PS. Inhalational anthrax. Ann NY Acad Sci 1980;353:83–93.

    Article  PubMed  CAS  Google Scholar 

  19. Freedman A, Afonja O, Chang WU, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002;287:869–874

    Article  PubMed  Google Scholar 

  20. Lew D. Bacillus anthracis (anthrax). In: Mandell GL, Bennett JE, Dolan R, eds. Principles and Practices of Infectious Disease. Churchill Livingstone, New York, 1995, pp. 1885–1889.

    Google Scholar 

  21. Amramova FA, Grinberg LM, Yampolskaya O, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak in 1979. Proc Natl Acad Sci USA 1993;90:2291–2294.

    Article  Google Scholar 

  22. Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol 1957;73:485–495.

    Article  Google Scholar 

  23. Dalldorf F, Kaufmann AF, Brachman PS. Woolsorter’s disease. Arch Pathol 1971;92:418–426.

    PubMed  CAS  Google Scholar 

  24. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933–944.

    Article  PubMed  CAS  Google Scholar 

  25. Barakat LA, Quentzel HL, Jernigan JA, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002;287:863–868.

    Article  PubMed  Google Scholar 

  26. Dahlgren CM, Buchanan LM, Decker HM, et al. Bacillus anthracis aerosols in goat hair processing mills. Am J Hyg 1960;72:24–31.

    PubMed  CAS  Google Scholar 

  27. Borio L, Frank D, Mani V, et al. Death due to bioterrorism-related inhalational anthrax: report of two patients. JAMA 2001;286:2554–2559.

    Article  PubMed  CAS  Google Scholar 

  28. Defense Intelligence Agency. Soviet Biological Warfare Threat. Publication DST-1610E-057–86. US Department of Defense, Washington, DC, 1986.

    Google Scholar 

  29. Peters CJ, Hartley DM. Anthrax inhalation and lethal human infection. Lancet 2002;359:710–711.

    Article  PubMed  CAS  Google Scholar 

  30. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR 2001;50:941–948.

    Google Scholar 

  31. Kuehnert MJ, Doyle TJ, Hill HA, et al. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. CID 2003;36:328–336.

    Article  Google Scholar 

  32. Grinberg LM, Abramova FA, Yampolskaya OV, et al. Quantitative pathology of inhalational anthrax I: Quantitative microscopic findings. Mod Pathol 2001;14:482–495.

    Article  PubMed  CAS  Google Scholar 

  33. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001;345:1607–1610.

    Article  PubMed  CAS  Google Scholar 

  34. Stepanov AV, Marinin LI, Pomerantsev AV, Staritsin NA. Development of novel vaccines against anthrax in man. J Biotechnol 1966;44:155–160.

    Article  Google Scholar 

  35. Lincoln R, Klein F, Walker J, et al. Successful treatment of monkeys for septicemic anthrax. Antimicrobial Agents and Chemotherapy, 1964. American Society for Microbiology; 1965, pp. 759–763.

    Google Scholar 

  36. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. MMWR 2001;50:909–919.

    Google Scholar 

  37. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR 2001;50:941–948.

    Google Scholar 

  38. Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax. JAMA 2002;287:579.

    Article  Google Scholar 

  39. Brookmeyer R, Blades N, Hugh-Jones M, Henderson D. The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. Biostatistics. 2001;2:233–247.

    Article  PubMed  Google Scholar 

  40. Centers for Disease Control and Prevention. Human anthrax associated with an epizootic among livestock North Dakota, 2000. MMWR 2001;50:677–680.

    Google Scholar 

  41. Centers for Disease Control and Prevention. Evaluation of postexposure antibiotic prophylaxis to prevent anthrax. MMWR 2002;51:59.

    Google Scholar 

  42. Hail AS, Rossi CA, Ludwig GW, et al. Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol challenge. Mil Med 1991 164:833–837.

    Google Scholar 

  43. Borio L, Frank D, Mani V, et al. Death due to bioterrorism-related anthrax. JAMA 2001;286:2554–2559.

    Article  PubMed  CAS  Google Scholar 

  44. American Hospital Formulary Service. AHFS Drug Information. American Society of Health System Pharmacists, Bethesda, MD, 1996.

    Google Scholar 

  45. Office of the Surgeon General, United States Army, Falls Church, VA. http://www.anthrax.osd.mil.

  46. Surveillance for adverse events associated with anthrax vaccination. MMWR 2000;49:341–345.

    Google Scholar 

  47. Hsu SS. Cost of anthrax cleanup on Hill to top $23 million, EPA says. Washington Post, March 7, 2002:A7.

    Google Scholar 

Download references

Authors
  1. Steven J. Durning MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Roy MD, MPH, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Michael J. Roy MD, MPH, FACP

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Durning, S.J., Roy, M.J. (2004). Anthrax. In: Roy, M.J. (eds) Physician’s Guide to Terrorist Attack. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-663-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-663-8_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9814-1

  • Online ISBN: 978-1-59259-663-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation